CREMON, CESARE
 Distribuzione geografica
Continente #
NA - Nord America 6.823
EU - Europa 3.482
AS - Asia 3.362
AF - Africa 270
SA - Sud America 219
Continente sconosciuto - Info sul continente non disponibili 158
OC - Oceania 16
Totale 14.330
Nazione #
US - Stati Uniti d'America 6.726
SG - Singapore 895
CN - Cina 815
VN - Vietnam 814
IT - Italia 770
GB - Regno Unito 705
DE - Germania 586
HK - Hong Kong 367
SE - Svezia 311
FR - Francia 191
UA - Ucraina 187
IN - India 156
BR - Brasile 149
RU - Federazione Russa 143
FI - Finlandia 134
IE - Irlanda 110
CH - Svizzera 68
JP - Giappone 67
ZA - Sudafrica 66
NG - Nigeria 65
CI - Costa d'Avorio 64
EE - Estonia 57
NL - Olanda 57
CA - Canada 54
TG - Togo 50
BD - Bangladesh 39
AT - Austria 37
BG - Bulgaria 37
KR - Corea 36
JO - Giordania 29
AR - Argentina 27
PH - Filippine 26
BE - Belgio 22
EC - Ecuador 15
IR - Iran 15
CO - Colombia 14
ID - Indonesia 14
SC - Seychelles 14
TH - Thailandia 14
TR - Turchia 14
AU - Australia 12
ES - Italia 12
IQ - Iraq 12
MX - Messico 12
PL - Polonia 11
GR - Grecia 9
TW - Taiwan 9
HN - Honduras 7
PK - Pakistan 7
SA - Arabia Saudita 7
RO - Romania 6
CR - Costa Rica 5
HR - Croazia 5
JM - Giamaica 5
MY - Malesia 4
NZ - Nuova Zelanda 4
SI - Slovenia 4
SM - San Marino 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
GT - Guatemala 3
IL - Israele 3
LB - Libano 3
PT - Portogallo 3
PY - Paraguay 3
RS - Serbia 3
TN - Tunisia 3
BA - Bosnia-Erzegovina 2
KE - Kenya 2
KH - Cambogia 2
LT - Lituania 2
MA - Marocco 2
NI - Nicaragua 2
PE - Perù 2
SV - El Salvador 2
UZ - Uzbekistan 2
AM - Armenia 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GD - Grenada 1
GH - Ghana 1
HT - Haiti 1
HU - Ungheria 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MN - Mongolia 1
MQ - Martinica 1
MT - Malta 1
MU - Mauritius 1
Totale 14.167
Città #
Houston 1.736
Singapore 624
Southend 601
Ashburn 471
Fairfield 466
Hong Kong 330
Chandler 313
San Jose 247
Dong Ket 225
Woodbridge 222
Munich 206
Wilmington 189
Seattle 176
Santa Clara 171
Cambridge 156
Hanoi 153
Ann Arbor 150
Princeton 138
Ho Chi Minh City 125
Council Bluffs 124
Beijing 115
Helsinki 113
Dublin 110
Los Angeles 110
Jacksonville 104
New York 93
Boardman 81
Nanjing 78
Bologna 77
Padova 71
Hefei 67
Abidjan 64
Lauterbourg 63
Westminster 62
Bern 60
Milan 60
Frankfurt am Main 57
Berlin 56
Dallas 52
Rome 51
Lomé 50
Tokyo 48
Jinan 37
Sofia 35
Bremen 34
Shenyang 34
Abeokuta 33
Buffalo 32
Vienna 32
Lagos 30
Saint Petersburg 30
Amman 29
Florence 29
Haiphong 29
Tianjin 26
Seoul 25
San Diego 24
Shanghai 24
Turin 24
Orem 23
Changsha 22
Da Nang 22
Dearborn 21
São Paulo 21
San Francisco 20
Brussels 19
Chicago 19
Guangzhou 19
Mülheim 19
Hebei 18
Phoenix 18
Toronto 18
Medford 16
Nanchang 16
Haikou 15
Mountain View 15
Verona 15
Denver 14
Norwalk 14
Redondo Beach 14
Atlanta 13
Falkenstein 13
Las Vegas 13
Montreal 13
Washington 13
Yubileyny 13
Hangzhou 12
Hải Dương 12
Mahé 12
Manchester 12
Bengaluru 11
Brooklyn 11
Jiaxing 11
Naples 11
Bắc Ninh 10
Charlotte 10
Chengdu 10
Des Moines 10
Falls Church 10
London 10
Totale 9.580
Nome #
New pathophysiological mechanisms in irritable bowel syndrome. 1.824
Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome 558
La sindrome dell'intestino irritabile. 385
Salmonella gastroenteritis during childhood is a risk factor for irritable bowel syndrome in adulthood 374
Randomised controlled trial of mesalazine in IBS 339
Il sistema nervoso enterico. 322
[Some practical questions on chronic stipsis treatment with prucalopride] 285
Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons 265
Sigmoid compliance and visceral perception in spinal cord injury patients 254
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. 252
Diagnosis and therapy of irritable bowel syndrome 246
Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome 244
Altered Serotonin Signaling and Extrinsic Sensory Neuron Activation in Irritable Bowel Syndrome 240
New insights into human enteric neuropathies. 227
The immune system in irritable bowel syndrome. 227
CLINICAL AND NEUROCHEMICAL FEATURES OF CHRONIC CONSTIPATION IN PATIENTS WITH PARKINSON DISEASE 224
Aminosalicylates and other anti-inflammatory compounds for irritable bowel syndrome. 223
Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. 222
MALATTIA DA REFLUSSO GASTROESOFAGEO 212
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 212
Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis 205
Gastroesophageal reflux disease: clinical and pathophysiological features (part I)] 204
Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome 203
Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. 201
Diagnostic challenges of symptomatic uncomplicated diverticular disease 200
Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS 198
Gut microbiota and related diseases: clinical features. 189
Gastroesophageal reflux disease: therapeutic features (Part II)] 188
Post-infectious Irritable Bowel Syndrome. 187
Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism 187
Almost all irritable bowel syndromes are post-infectious and respond to probiotics: controversial issues. 186
Serine proteases: new players in diarrhoea-predominant irritable bowel syndrome 180
Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. 180
null 179
Interactions between commensal bacteria and gut sensorimotor function in health and disease. 176
Enteric neuron involvement in dysmotilities and responses to inflammation. 174
Antiflagellin antibodies suggest infective participation in irritable bowel syndrome pathogenesis. 171
Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use. 170
Malattia da reflusso gastroesofageo. 170
Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. 169
Inflammatory bowel disease and irritable bowel syndrome: similarities and differences 168
Supernatants of irritable bowel syndrome mucosal biopsies impair human colonic smooth muscle contractility 164
Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. 162
Postinfectious irritable bowel syndrome. 160
Patient-reported outcomes and gut dysmotility in functional gastrointestinal disorders. 159
Colonic mucosal mast cell mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons. 157
Reduced Bcl-2 expression and increased myenteric neuron apoptosis in patients with idiopathic enteric neuropathy (IEN) 155
Nerve Growth and Plasticity in the Colonic Mucosa of Patients With Irritable Bowel Syndrome 152
La sindrome dell’intestino irritabile: novita’ sulla fisiopatologia. 151
Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. 149
Natural history of intestinal failure induced by chronic idiopathic intestinal pseudo-obstruction 149
How relevant is symptom evaluation in NERD? 148
Treatment of diverticular disease with aminosalicylates: The evidence 148
Idiopathic achalasia is not allelic to alacrima achalasia adrenal insufficiency syndrome at the ALADIN locus 145
Neuro-immune interactions and anorectal motility in children with food-allergy related constipation. 144
Neuroimmune interaction and anorectal motility in children with food allergy-related chronic constipation. 136
Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. 134
Norovirus gastroenteritis. 131
Mast cells are increased in the colonic mucosa of patients with irritable bowel syndrome and excite visceral sensory pathways. 126
The effect of colonic mucosal mediators from patients with irritable bowel syndrome on tritiated Ach release and motor responses in strips of human colon. 121
Allergic Proctocolitis Is a Risk Factor for Functional Gastrointestinal Disorders in Children 117
What is the effect of inflammation on intestinal function? 110
null 108
Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: a randomized, double-blind, placebo controlled trial 107
null 77
Totale 14.330
Categoria #
all - tutte 34.316
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.316


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.250 0 0 0 79 100 67 52 76 43 76 511 246
2022/20231.489 151 222 116 204 110 105 24 89 234 35 84 115
2023/2024481 39 64 46 45 54 128 28 12 6 19 18 22
2024/20251.632 83 233 145 97 240 123 172 139 100 42 25 233
2025/20263.238 193 241 292 218 351 184 462 107 725 223 127 115
2026/2027888 218 360 248 62 0 0 0 0 0 0 0 0
Totale 14.330